Dabigatran = Pradaxa for Atrial Fibrillation

Medical News: Dabigatran Wins FDA Nod for Stroke Prevention in Afib Patients – in Cardiovascular, Arrhythmias from MedPage Today

The anticoagulant drug dabigatran (Pradaxa) was cleared for market for preventing strokes and thrombosis in patients with atrial fibrillation, the FDA announced.

Leave a comment